nodes	percent_of_prediction	percent_of_DWPC	metapath
Caffeine—migraine—Prednisone—ankylosing spondylitis	0.6	1	CpDpCtD
Caffeine—CYP1B1—Dexamethasone—ankylosing spondylitis	0.0432	0.152	CbGbCtD
Caffeine—CYP3A5—Sulfasalazine—ankylosing spondylitis	0.0228	0.0802	CbGbCtD
Caffeine—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0196	0.0689	CbGbCtD
Caffeine—CYP1A1—Dexamethasone—ankylosing spondylitis	0.019	0.0667	CbGbCtD
Caffeine—CYP3A7-CYP3A51P—Dexamethasone—ankylosing spondylitis	0.0152	0.0534	CbGbCtD
Caffeine—CYP3A7—Dexamethasone—ankylosing spondylitis	0.0152	0.0534	CbGbCtD
Caffeine—CYP2E1—Dexamethasone—ankylosing spondylitis	0.0147	0.0515	CbGbCtD
Caffeine—ABCB1—Betamethasone—ankylosing spondylitis	0.0127	0.0448	CbGbCtD
Caffeine—ABCB1—Prednisolone—ankylosing spondylitis	0.0126	0.0442	CbGbCtD
Caffeine—ABCB1—Prednisone—ankylosing spondylitis	0.0119	0.0417	CbGbCtD
Caffeine—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0117	0.0413	CbGbCtD
Caffeine—CYP3A5—Dexamethasone—ankylosing spondylitis	0.0114	0.04	CbGbCtD
Caffeine—CYP2C8—Dexamethasone—ankylosing spondylitis	0.0109	0.0385	CbGbCtD
Caffeine—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0089	0.0313	CbGbCtD
Caffeine—Retinopathy of prematurity—Dexamethasone—ankylosing spondylitis	0.00801	0.148	CcSEcCtD
Caffeine—Retinopathy of prematurity—Betamethasone—ankylosing spondylitis	0.00801	0.148	CcSEcCtD
Caffeine—CYP2C9—Dexamethasone—ankylosing spondylitis	0.00764	0.0268	CbGbCtD
Caffeine—CYP3A4—Betamethasone—ankylosing spondylitis	0.00763	0.0268	CbGbCtD
Caffeine—CYP3A4—Prednisolone—ankylosing spondylitis	0.00753	0.0265	CbGbCtD
Caffeine—ABCB1—Dexamethasone—ankylosing spondylitis	0.00741	0.026	CbGbCtD
Caffeine—CYP3A4—Prednisone—ankylosing spondylitis	0.00711	0.025	CbGbCtD
Caffeine—CYP2D6—Dexamethasone—ankylosing spondylitis	0.00698	0.0245	CbGbCtD
Caffeine—ABCB1—Methotrexate—ankylosing spondylitis	0.00595	0.0209	CbGbCtD
Caffeine—CYP3A4—Dexamethasone—ankylosing spondylitis	0.00444	0.0156	CbGbCtD
Caffeine—Ca++ increased—Methylprednisolone—ankylosing spondylitis	0.00423	0.0783	CcSEcCtD
Caffeine—Impaired healing—Prednisolone—ankylosing spondylitis	0.00134	0.0247	CcSEcCtD
Caffeine—Impaired healing—Triamcinolone—ankylosing spondylitis	0.00123	0.0228	CcSEcCtD
Caffeine—Impaired healing—Methylprednisolone—ankylosing spondylitis	0.00123	0.0227	CcSEcCtD
Caffeine—PRKDC—Testosterone—Prednisolone—ankylosing spondylitis	0.00113	0.546	CbGdCrCtD
Caffeine—Impaired healing—Betamethasone—ankylosing spondylitis	0.00112	0.0206	CcSEcCtD
Caffeine—Impaired healing—Dexamethasone—ankylosing spondylitis	0.00112	0.0206	CcSEcCtD
Caffeine—Impaired healing—Prednisone—ankylosing spondylitis	0.000972	0.018	CcSEcCtD
Caffeine—PRKDC—Danazol—Prednisone—ankylosing spondylitis	0.000942	0.454	CbGdCrCtD
Caffeine—Impaired healing—Methotrexate—ankylosing spondylitis	0.000812	0.015	CcSEcCtD
Caffeine—Hypercalcaemia—Methylprednisolone—ankylosing spondylitis	0.000764	0.0141	CcSEcCtD
Caffeine—Pulmonary oedema—Prednisolone—ankylosing spondylitis	0.000515	0.00952	CcSEcCtD
Caffeine—PIK3CA—a6b1 and a6b4 Integrin signaling—IL1A—ankylosing spondylitis	0.000489	0.00817	CbGpPWpGaD
Caffeine—PIK3CD—Cytokine Signaling in Immune system—IL1R2—ankylosing spondylitis	0.000484	0.00809	CbGpPWpGaD
Caffeine—Pulmonary oedema—Triamcinolone—ankylosing spondylitis	0.000473	0.00876	CcSEcCtD
Caffeine—Pulmonary oedema—Methylprednisolone—ankylosing spondylitis	0.000472	0.00874	CcSEcCtD
Caffeine—Injury—Prednisolone—ankylosing spondylitis	0.000457	0.00845	CcSEcCtD
Caffeine—PRKDC—FAS pathway and Stress induction of HSP regulation—TNF—ankylosing spondylitis	0.000444	0.00743	CbGpPWpGaD
Caffeine—PIK3CB—Toll-like Receptor Signaling Pathway—IL12B—ankylosing spondylitis	0.000438	0.00732	CbGpPWpGaD
Caffeine—PIK3CA—BCR signaling pathway—CD79A—ankylosing spondylitis	0.000433	0.00725	CbGpPWpGaD
Caffeine—PIK3CD—Adaptive Immune System—KIR3DL1—ankylosing spondylitis	0.00043	0.00719	CbGpPWpGaD
Caffeine—Pulmonary oedema—Dexamethasone—ankylosing spondylitis	0.00043	0.00795	CcSEcCtD
Caffeine—Pulmonary oedema—Betamethasone—ankylosing spondylitis	0.00043	0.00795	CcSEcCtD
Caffeine—PIK3CB—Signaling by Interleukins—IL1RN—ankylosing spondylitis	0.000428	0.00715	CbGpPWpGaD
Caffeine—PIK3CB—Cytokine Signaling in Immune system—IL1R2—ankylosing spondylitis	0.000422	0.00705	CbGpPWpGaD
Caffeine—Injury—Triamcinolone—ankylosing spondylitis	0.00042	0.00777	CcSEcCtD
Caffeine—Injury—Methylprednisolone—ankylosing spondylitis	0.000419	0.00775	CcSEcCtD
Caffeine—PRKDC—Immune System—KIR3DL1—ankylosing spondylitis	0.000408	0.00681	CbGpPWpGaD
Caffeine—ADORA2B—G alpha (s) signalling events—PTGER4—ankylosing spondylitis	0.000406	0.00678	CbGpPWpGaD
Caffeine—PIK3CA—IL6-mediated signaling events—CRP—ankylosing spondylitis	0.000395	0.00659	CbGpPWpGaD
Caffeine—PIK3CD—Regulation of toll-like receptor signaling pathway—IL12B—ankylosing spondylitis	0.000392	0.00656	CbGpPWpGaD
Caffeine—Dry skin—Prednisolone—ankylosing spondylitis	0.000385	0.00712	CcSEcCtD
Caffeine—Injury—Betamethasone—ankylosing spondylitis	0.000381	0.00705	CcSEcCtD
Caffeine—Injury—Dexamethasone—ankylosing spondylitis	0.000381	0.00705	CcSEcCtD
Caffeine—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL12B—ankylosing spondylitis	0.000381	0.00637	CbGpPWpGaD
Caffeine—PIK3CD—DAP12 interactions—HLA-C—ankylosing spondylitis	0.00038	0.00636	CbGpPWpGaD
Caffeine—PIK3CA—IL4-mediated signaling events—IL10—ankylosing spondylitis	0.000376	0.00628	CbGpPWpGaD
Caffeine—PIK3CA—IL4-mediated signaling events—CD40LG—ankylosing spondylitis	0.000376	0.00628	CbGpPWpGaD
Caffeine—PIK3CB—Adaptive Immune System—KIR3DL1—ankylosing spondylitis	0.000375	0.00627	CbGpPWpGaD
Caffeine—Pulmonary oedema—Prednisone—ankylosing spondylitis	0.000374	0.00692	CcSEcCtD
Caffeine—PRKDC—Innate Immune System—CARD9—ankylosing spondylitis	0.000368	0.00615	CbGpPWpGaD
Caffeine—Irritability—Methylprednisolone—ankylosing spondylitis	0.000368	0.0068	CcSEcCtD
Caffeine—PIK3CA—p75(NTR)-mediated signaling—MMP3—ankylosing spondylitis	0.000367	0.00614	CbGpPWpGaD
Caffeine—Sepsis—Prednisone—ankylosing spondylitis	0.000365	0.00675	CcSEcCtD
Caffeine—PIK3CD—Signaling by Interleukins—IL1A—ankylosing spondylitis	0.000353	0.0059	CbGpPWpGaD
Caffeine—PIK3CA—Toll-like Receptor Signaling Pathway—IL12B—ankylosing spondylitis	0.000345	0.00577	CbGpPWpGaD
Caffeine—PIK3CB—Regulation of toll-like receptor signaling pathway—IL12B—ankylosing spondylitis	0.000342	0.00572	CbGpPWpGaD
Caffeine—PDE4B—G alpha (s) signalling events—PTGER4—ankylosing spondylitis	0.000341	0.0057	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by Interleukins—IL1RN—ankylosing spondylitis	0.000337	0.00563	CbGpPWpGaD
Caffeine—Irritability—Betamethasone—ankylosing spondylitis	0.000334	0.00619	CcSEcCtD
Caffeine—Irritability—Dexamethasone—ankylosing spondylitis	0.000334	0.00619	CcSEcCtD
Caffeine—PIK3CA—Cytokine Signaling in Immune system—IL1R2—ankylosing spondylitis	0.000332	0.00556	CbGpPWpGaD
Caffeine—Injury—Prednisone—ankylosing spondylitis	0.000332	0.00614	CcSEcCtD
Caffeine—PIK3CB—DAP12 interactions—HLA-C—ankylosing spondylitis	0.000332	0.00554	CbGpPWpGaD
Caffeine—Dry skin—Dexamethasone—ankylosing spondylitis	0.000321	0.00594	CcSEcCtD
Caffeine—Dry skin—Betamethasone—ankylosing spondylitis	0.000321	0.00594	CcSEcCtD
Caffeine—Urine output increased—Methotrexate—ankylosing spondylitis	0.000318	0.00588	CcSEcCtD
Caffeine—Pulmonary oedema—Methotrexate—ankylosing spondylitis	0.000313	0.00578	CcSEcCtD
Caffeine—PIK3CB—Signaling by Interleukins—IL1A—ankylosing spondylitis	0.000308	0.00515	CbGpPWpGaD
Caffeine—Gastrointestinal haemorrhage—Prednisone—ankylosing spondylitis	0.000305	0.00564	CcSEcCtD
Caffeine—Sepsis—Methotrexate—ankylosing spondylitis	0.000305	0.00564	CcSEcCtD
Caffeine—Infestation—Methylprednisolone—ankylosing spondylitis	0.000297	0.00549	CcSEcCtD
Caffeine—Infestation NOS—Methylprednisolone—ankylosing spondylitis	0.000297	0.00549	CcSEcCtD
Caffeine—PIK3CD—Toll-like Receptor Signaling Pathway—TLR4—ankylosing spondylitis	0.000296	0.00495	CbGpPWpGaD
Caffeine—PIK3CA—Adaptive Immune System—KIR3DL1—ankylosing spondylitis	0.000296	0.00494	CbGpPWpGaD
Caffeine—Haemoglobin—Prednisolone—ankylosing spondylitis	0.000292	0.0054	CcSEcCtD
Caffeine—Irritability—Prednisone—ankylosing spondylitis	0.000291	0.00539	CcSEcCtD
Caffeine—Haemorrhage—Prednisolone—ankylosing spondylitis	0.00029	0.00537	CcSEcCtD
Caffeine—Dry skin—Prednisone—ankylosing spondylitis	0.00028	0.00517	CcSEcCtD
Caffeine—Hyperglycaemia—Betamethasone—ankylosing spondylitis	0.000273	0.00505	CcSEcCtD
Caffeine—Hyperglycaemia—Dexamethasone—ankylosing spondylitis	0.000273	0.00505	CcSEcCtD
Caffeine—PIK3CA—Regulation of toll-like receptor signaling pathway—IL12B—ankylosing spondylitis	0.00027	0.00451	CbGpPWpGaD
Caffeine—PIK3CD—B Cell Activation—CD79A—ankylosing spondylitis	0.000268	0.00449	CbGpPWpGaD
Caffeine—Haemoglobin—Triamcinolone—ankylosing spondylitis	0.000268	0.00497	CcSEcCtD
Caffeine—Haemoglobin—Methylprednisolone—ankylosing spondylitis	0.000268	0.00496	CcSEcCtD
Caffeine—Haemorrhage—Triamcinolone—ankylosing spondylitis	0.000267	0.00494	CcSEcCtD
Caffeine—Haemorrhage—Methylprednisolone—ankylosing spondylitis	0.000266	0.00493	CcSEcCtD
Caffeine—ADORA2A—G alpha (s) signalling events—PTGER4—ankylosing spondylitis	0.000266	0.00445	CbGpPWpGaD
Caffeine—PIK3CD—Cytokine Signaling in Immune system—HLA-C—ankylosing spondylitis	0.000264	0.00441	CbGpPWpGaD
Caffeine—PIK3CA—DAP12 interactions—HLA-C—ankylosing spondylitis	0.000261	0.00437	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—KIR3DL1—ankylosing spondylitis	0.000261	0.00436	CbGpPWpGaD
Caffeine—PIK3CB—Toll-like Receptor Signaling Pathway—TLR4—ankylosing spondylitis	0.000258	0.00432	CbGpPWpGaD
Caffeine—ATM—Cellular Senescence—IL1A—ankylosing spondylitis	0.000254	0.00424	CbGpPWpGaD
Caffeine—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	0.000247	0.00458	CcSEcCtD
Caffeine—PIK3CD—Adaptive Immune System—ERAP1—ankylosing spondylitis	0.000247	0.00413	CbGpPWpGaD
Caffeine—PRKDC—Immune System—IL1R2—ankylosing spondylitis	0.000247	0.00413	CbGpPWpGaD
Caffeine—Haemoglobin—Betamethasone—ankylosing spondylitis	0.000244	0.00451	CcSEcCtD
Caffeine—Haemoglobin—Dexamethasone—ankylosing spondylitis	0.000244	0.00451	CcSEcCtD
Caffeine—Irritability—Methotrexate—ankylosing spondylitis	0.000243	0.0045	CcSEcCtD
Caffeine—PIK3CA—Signaling by Interleukins—IL1A—ankylosing spondylitis	0.000243	0.00405	CbGpPWpGaD
Caffeine—Haemorrhage—Betamethasone—ankylosing spondylitis	0.000242	0.00448	CcSEcCtD
Caffeine—Haemorrhage—Dexamethasone—ankylosing spondylitis	0.000242	0.00448	CcSEcCtD
Caffeine—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.000241	0.00445	CcSEcCtD
Caffeine—Hyperglycaemia—Prednisone—ankylosing spondylitis	0.000238	0.0044	CcSEcCtD
Caffeine—PIK3CD—Innate Immune System—CARD9—ankylosing spondylitis	0.000235	0.00393	CbGpPWpGaD
Caffeine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—ankylosing spondylitis	0.000235	0.00392	CbGpPWpGaD
Caffeine—PRKDC—Immune System—ERAP1—ankylosing spondylitis	0.000234	0.00391	CbGpPWpGaD
Caffeine—PIK3CB—B Cell Activation—CD79A—ankylosing spondylitis	0.000234	0.00391	CbGpPWpGaD
Caffeine—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.000232	0.00429	CcSEcCtD
Caffeine—PIK3CD—Regulation of toll-like receptor signaling pathway—TLR4—ankylosing spondylitis	0.000231	0.00387	CbGpPWpGaD
Caffeine—PRKDC—Innate Immune System—HLA-C—ankylosing spondylitis	0.000231	0.00386	CbGpPWpGaD
Caffeine—PIK3CB—Cytokine Signaling in Immune system—HLA-C—ankylosing spondylitis	0.00023	0.00384	CbGpPWpGaD
Caffeine—PIK3CD—Cytokine Signaling in Immune system—IL1RN—ankylosing spondylitis	0.000229	0.00383	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—KIR3DL1—ankylosing spondylitis	0.000227	0.0038	CbGpPWpGaD
Caffeine—ADORA2B—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	0.000226	0.00377	CbGpPWpGaD
Caffeine—PIK3CD—DAP12 interactions—HLA-B—ankylosing spondylitis	0.000225	0.00376	CbGpPWpGaD
Caffeine—Convulsion—Prednisolone—ankylosing spondylitis	0.000219	0.00405	CcSEcCtD
Caffeine—Hypertension—Prednisolone—ankylosing spondylitis	0.000218	0.00404	CcSEcCtD
Caffeine—PIK3CA—IL23-mediated signaling events—TNF—ankylosing spondylitis	0.000216	0.00361	CbGpPWpGaD
Caffeine—PIK3CB—Adaptive Immune System—ERAP1—ankylosing spondylitis	0.000215	0.0036	CbGpPWpGaD
Caffeine—PRKDC—Immune System—CARD9—ankylosing spondylitis	0.000214	0.00358	CbGpPWpGaD
Caffeine—Haemoglobin—Prednisone—ankylosing spondylitis	0.000212	0.00392	CcSEcCtD
Caffeine—Haemorrhage—Prednisone—ankylosing spondylitis	0.000211	0.0039	CcSEcCtD
Caffeine—PIK3CB—Innate Immune System—CARD9—ankylosing spondylitis	0.000205	0.00343	CbGpPWpGaD
Caffeine—PIK3CA—Toll-like Receptor Signaling Pathway—TLR4—ankylosing spondylitis	0.000203	0.0034	CbGpPWpGaD
Caffeine—PIK3CB—Regulation of toll-like receptor signaling pathway—TLR4—ankylosing spondylitis	0.000202	0.00337	CbGpPWpGaD
Caffeine—Convulsion—Triamcinolone—ankylosing spondylitis	0.000201	0.00373	CcSEcCtD
Caffeine—Tachycardia—Prednisolone—ankylosing spondylitis	0.000201	0.00373	CcSEcCtD
Caffeine—Convulsion—Methylprednisolone—ankylosing spondylitis	0.000201	0.00372	CcSEcCtD
Caffeine—Hypertension—Triamcinolone—ankylosing spondylitis	0.000201	0.00371	CcSEcCtD
Caffeine—ADORA2A—Monoamine Transport—TNF—ankylosing spondylitis	0.0002	0.00335	CbGpPWpGaD
Caffeine—Hypertension—Methylprednisolone—ankylosing spondylitis	0.0002	0.00371	CcSEcCtD
Caffeine—PIK3CB—Cytokine Signaling in Immune system—IL1RN—ankylosing spondylitis	0.0002	0.00334	CbGpPWpGaD
Caffeine—Infestation NOS—Methotrexate—ankylosing spondylitis	0.000196	0.00364	CcSEcCtD
Caffeine—Infestation—Methotrexate—ankylosing spondylitis	0.000196	0.00364	CcSEcCtD
Caffeine—PIK3CB—DAP12 interactions—HLA-B—ankylosing spondylitis	0.000196	0.00328	CbGpPWpGaD
Caffeine—ADORA2B—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.000193	0.00323	CbGpPWpGaD
Caffeine—Renal failure—Methotrexate—ankylosing spondylitis	0.000193	0.00357	CcSEcCtD
Caffeine—ADORA1—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	0.000192	0.00321	CbGpPWpGaD
Caffeine—ATM—Cellular responses to stress—IL1A—ankylosing spondylitis	0.000192	0.0032	CbGpPWpGaD
Caffeine—Immune system disorder—Prednisone—ankylosing spondylitis	0.000191	0.00353	CcSEcCtD
Caffeine—Infection—Triamcinolone—ankylosing spondylitis	0.000188	0.00349	CcSEcCtD
Caffeine—Infection—Methylprednisolone—ankylosing spondylitis	0.000188	0.00348	CcSEcCtD
Caffeine—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000186	0.00344	CcSEcCtD
Caffeine—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000185	0.00343	CcSEcCtD
Caffeine—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000185	0.00342	CcSEcCtD
Caffeine—PIK3CA—B Cell Activation—CD79A—ankylosing spondylitis	0.000184	0.00308	CbGpPWpGaD
Caffeine—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000184	0.0034	CcSEcCtD
Caffeine—Malnutrition—Prednisone—ankylosing spondylitis	0.000184	0.0034	CcSEcCtD
Caffeine—Convulsion—Dexamethasone—ankylosing spondylitis	0.000183	0.00338	CcSEcCtD
Caffeine—Convulsion—Betamethasone—ankylosing spondylitis	0.000183	0.00338	CcSEcCtD
Caffeine—PIK3CD—Disease—ANTXR2—ankylosing spondylitis	0.000183	0.00305	CbGpPWpGaD
Caffeine—Hypertension—Betamethasone—ankylosing spondylitis	0.000182	0.00337	CcSEcCtD
Caffeine—Hypertension—Dexamethasone—ankylosing spondylitis	0.000182	0.00337	CcSEcCtD
Caffeine—PIK3CA—Cytokine Signaling in Immune system—HLA-C—ankylosing spondylitis	0.000181	0.00303	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—KIR3DL1—ankylosing spondylitis	0.000179	0.003	CbGpPWpGaD
Caffeine—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000177	0.00328	CcSEcCtD
Caffeine—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000176	0.00326	CcSEcCtD
Caffeine—Infection—Betamethasone—ankylosing spondylitis	0.000171	0.00316	CcSEcCtD
Caffeine—Infection—Dexamethasone—ankylosing spondylitis	0.000171	0.00316	CcSEcCtD
Caffeine—PIK3CA—Angiopoietin receptor Tie2-mediated signaling—TNF—ankylosing spondylitis	0.00017	0.00284	CbGpPWpGaD
Caffeine—PIK3CA—Adaptive Immune System—ERAP1—ankylosing spondylitis	0.00017	0.00284	CbGpPWpGaD
Caffeine—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000169	0.00313	CcSEcCtD
Caffeine—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000169	0.00312	CcSEcCtD
Caffeine—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000169	0.00312	CcSEcCtD
Caffeine—Agitation—Prednisone—ankylosing spondylitis	0.000169	0.00312	CcSEcCtD
Caffeine—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000168	0.00311	CcSEcCtD
Caffeine—Tachycardia—Betamethasone—ankylosing spondylitis	0.000168	0.00311	CcSEcCtD
Caffeine—PIK3CD—Cytokine Signaling in Immune system—IL1A—ankylosing spondylitis	0.000165	0.00275	CbGpPWpGaD
Caffeine—ADORA1—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.000164	0.00275	CbGpPWpGaD
Caffeine—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000164	0.00303	CcSEcCtD
Caffeine—PIK3CD—MicroRNAs in cardiomyocyte hypertrophy—TNF—ankylosing spondylitis	0.000163	0.00273	CbGpPWpGaD
Caffeine—PIK3CA—Innate Immune System—CARD9—ankylosing spondylitis	0.000162	0.0027	CbGpPWpGaD
Caffeine—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000159	0.00295	CcSEcCtD
Caffeine—Convulsion—Prednisone—ankylosing spondylitis	0.000159	0.00295	CcSEcCtD
Caffeine—PIK3CB—Disease—ANTXR2—ankylosing spondylitis	0.000159	0.00266	CbGpPWpGaD
Caffeine—PIK3CA—Regulation of toll-like receptor signaling pathway—TLR4—ankylosing spondylitis	0.000159	0.00266	CbGpPWpGaD
Caffeine—Hypertension—Prednisone—ankylosing spondylitis	0.000159	0.00293	CcSEcCtD
Caffeine—PIK3CD—Immune System—IL1R2—ankylosing spondylitis	0.000158	0.00264	CbGpPWpGaD
Caffeine—PIK3CA—Cytokine Signaling in Immune system—IL1RN—ankylosing spondylitis	0.000157	0.00263	CbGpPWpGaD
Caffeine—PIK3CD—Cytokine Signaling in Immune system—HLA-B—ankylosing spondylitis	0.000156	0.00261	CbGpPWpGaD
Caffeine—PIK3CA—DAP12 interactions—HLA-B—ankylosing spondylitis	0.000155	0.00258	CbGpPWpGaD
Caffeine—Malnutrition—Methotrexate—ankylosing spondylitis	0.000154	0.00284	CcSEcCtD
Caffeine—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000152	0.00281	CcSEcCtD
Caffeine—PIK3CD—Immune System—ERAP1—ankylosing spondylitis	0.00015	0.00251	CbGpPWpGaD
Caffeine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—ankylosing spondylitis	0.00015	0.0025	CbGpPWpGaD
Caffeine—Infection—Prednisone—ankylosing spondylitis	0.000149	0.00276	CcSEcCtD
Caffeine—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000149	0.00275	CcSEcCtD
Caffeine—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000149	0.00275	CcSEcCtD
Caffeine—ADORA2A—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	0.000148	0.00248	CbGpPWpGaD
Caffeine—PIK3CA—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—ankylosing spondylitis	0.000148	0.00247	CbGpPWpGaD
Caffeine—PIK3CD—Innate Immune System—HLA-C—ankylosing spondylitis	0.000148	0.00247	CbGpPWpGaD
Caffeine—ADORA2B—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.000147	0.00246	CbGpPWpGaD
Caffeine—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000147	0.00272	CcSEcCtD
Caffeine—Tachycardia—Prednisone—ankylosing spondylitis	0.000146	0.00271	CcSEcCtD
Caffeine—Skin disorder—Prednisone—ankylosing spondylitis	0.000146	0.00269	CcSEcCtD
Caffeine—PIK3CD—Cytokine Signaling in Immune system—HLA-A—ankylosing spondylitis	0.000144	0.00241	CbGpPWpGaD
Caffeine—PIK3CB—Cytokine Signaling in Immune system—IL1A—ankylosing spondylitis	0.000144	0.0024	CbGpPWpGaD
Caffeine—ABCB1—Allograft Rejection—HLA-C—ankylosing spondylitis	0.000143	0.00239	CbGpPWpGaD
Caffeine—PIK3CB—MicroRNAs in cardiomyocyte hypertrophy—TNF—ankylosing spondylitis	0.000142	0.00238	CbGpPWpGaD
Caffeine—PIK3CD—Adaptive Immune System—HLA-C—ankylosing spondylitis	0.000142	0.00237	CbGpPWpGaD
Caffeine—PIK3CD—Toll-like Receptor Signaling Pathway—TNF—ankylosing spondylitis	0.00014	0.00234	CbGpPWpGaD
Caffeine—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00014	0.00259	CcSEcCtD
Caffeine—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000139	0.00258	CcSEcCtD
Caffeine—PIK3CB—Immune System—IL1R2—ankylosing spondylitis	0.000138	0.0023	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—CARD9—ankylosing spondylitis	0.000137	0.00229	CbGpPWpGaD
Caffeine—PRKDC—Innate Immune System—HLA-B—ankylosing spondylitis	0.000137	0.00228	CbGpPWpGaD
Caffeine—PIK3CB—Cytokine Signaling in Immune system—HLA-B—ankylosing spondylitis	0.000136	0.00227	CbGpPWpGaD
Caffeine—PRKDC—Immune System—HLA-C—ankylosing spondylitis	0.000134	0.00225	CbGpPWpGaD
Caffeine—Convulsion—Methotrexate—ankylosing spondylitis	0.000133	0.00246	CcSEcCtD
Caffeine—ABCB1—Allograft Rejection—IL17A—ankylosing spondylitis	0.000131	0.00219	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—ERAP1—ankylosing spondylitis	0.000131	0.00218	CbGpPWpGaD
Caffeine—Rash—Prednisolone—ankylosing spondylitis	0.00013	0.00241	CcSEcCtD
Caffeine—Dermatitis—Prednisolone—ankylosing spondylitis	0.00013	0.0024	CcSEcCtD
Caffeine—PIK3CB—Innate Immune System—HLA-C—ankylosing spondylitis	0.000129	0.00215	CbGpPWpGaD
Caffeine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.000127	0.00212	CbGpPWpGaD
Caffeine—PIK3CB—Cytokine Signaling in Immune system—HLA-A—ankylosing spondylitis	0.000126	0.0021	CbGpPWpGaD
Caffeine—PIK3CA—Disease—ANTXR2—ankylosing spondylitis	0.000125	0.0021	CbGpPWpGaD
Caffeine—ADORA1—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.000125	0.00209	CbGpPWpGaD
Caffeine—Infection—Methotrexate—ankylosing spondylitis	0.000124	0.0023	CcSEcCtD
Caffeine—PIK3CB—Adaptive Immune System—HLA-C—ankylosing spondylitis	0.000124	0.00207	CbGpPWpGaD
Caffeine—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000123	0.00227	CcSEcCtD
Caffeine—PIK3CB—Toll-like Receptor Signaling Pathway—TNF—ankylosing spondylitis	0.000122	0.00204	CbGpPWpGaD
Caffeine—Skin disorder—Methotrexate—ankylosing spondylitis	0.000122	0.00225	CcSEcCtD
Caffeine—ABCB1—Allograft Rejection—IL12B—ankylosing spondylitis	0.000122	0.00203	CbGpPWpGaD
Caffeine—PRKDC—Innate Immune System—CRP—ankylosing spondylitis	0.000121	0.00202	CbGpPWpGaD
Caffeine—Rash—Triamcinolone—ankylosing spondylitis	0.00012	0.00221	CcSEcCtD
Caffeine—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00012	0.00221	CcSEcCtD
Caffeine—PIK3CB—Immune System—CARD9—ankylosing spondylitis	0.000119	0.002	CbGpPWpGaD
Caffeine—Rash—Methylprednisolone—ankylosing spondylitis	0.000119	0.00221	CcSEcCtD
Caffeine—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000119	0.00221	CcSEcCtD
Caffeine—PRKDC—Immune System—IL1RN—ankylosing spondylitis	0.000117	0.00195	CbGpPWpGaD
Caffeine—PRKDC—Innate Immune System—TLR4—ankylosing spondylitis	0.000116	0.00193	CbGpPWpGaD
Caffeine—PIK3CA—Cytokine Signaling in Immune system—IL1A—ankylosing spondylitis	0.000113	0.00189	CbGpPWpGaD
Caffeine—PIK3CA—MicroRNAs in cardiomyocyte hypertrophy—TNF—ankylosing spondylitis	0.000112	0.00188	CbGpPWpGaD
Caffeine—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000112	0.00207	CcSEcCtD
Caffeine—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00011	0.00204	CcSEcCtD
Caffeine—PIK3CD—Regulation of toll-like receptor signaling pathway—TNF—ankylosing spondylitis	0.000109	0.00183	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—IL1R2—ankylosing spondylitis	0.000109	0.00182	CbGpPWpGaD
Caffeine—Rash—Dexamethasone—ankylosing spondylitis	0.000109	0.00201	CcSEcCtD
Caffeine—Rash—Betamethasone—ankylosing spondylitis	0.000109	0.00201	CcSEcCtD
Caffeine—Dermatitis—Betamethasone—ankylosing spondylitis	0.000108	0.00201	CcSEcCtD
Caffeine—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000108	0.00201	CcSEcCtD
Caffeine—PIK3CD—Adaptive Immune System—CD79A—ankylosing spondylitis	0.000108	0.00181	CbGpPWpGaD
Caffeine—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000108	0.002	CcSEcCtD
Caffeine—PIK3CD—Disease—B3GNT2—ankylosing spondylitis	0.000108	0.0018	CbGpPWpGaD
Caffeine—PIK3CA—Cytokine Signaling in Immune system—HLA-B—ankylosing spondylitis	0.000107	0.00179	CbGpPWpGaD
Caffeine—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—ankylosing spondylitis	0.000106	0.00177	CbGpPWpGaD
Caffeine—CYP1B1—Aryl Hydrocarbon Receptor—TNF—ankylosing spondylitis	0.000106	0.00177	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—ERAP1—ankylosing spondylitis	0.000103	0.00172	CbGpPWpGaD
Caffeine—PRKDC—Immune System—CD79A—ankylosing spondylitis	0.000103	0.00171	CbGpPWpGaD
Caffeine—PIK3CA—Innate Immune System—HLA-C—ankylosing spondylitis	0.000102	0.0017	CbGpPWpGaD
Caffeine—PIK3CA—Cytokine Signaling in Immune system—HLA-A—ankylosing spondylitis	9.92e-05	0.00166	CbGpPWpGaD
Caffeine—PIK3CA—Adaptive Immune System—HLA-C—ankylosing spondylitis	9.75e-05	0.00163	CbGpPWpGaD
Caffeine—ADORA2A—GPCR ligand binding—PTGER4—ankylosing spondylitis	9.67e-05	0.00162	CbGpPWpGaD
Caffeine—PIK3CD—GPCR downstream signaling—PTGER4—ankylosing spondylitis	9.64e-05	0.00161	CbGpPWpGaD
Caffeine—PIK3CA—Toll-like Receptor Signaling Pathway—TNF—ankylosing spondylitis	9.61e-05	0.00161	CbGpPWpGaD
Caffeine—PIK3CB—Regulation of toll-like receptor signaling pathway—TNF—ankylosing spondylitis	9.52e-05	0.00159	CbGpPWpGaD
Caffeine—Rash—Prednisone—ankylosing spondylitis	9.45e-05	0.00175	CcSEcCtD
Caffeine—Dermatitis—Prednisone—ankylosing spondylitis	9.44e-05	0.00175	CcSEcCtD
Caffeine—PIK3CB—Adaptive Immune System—CD79A—ankylosing spondylitis	9.43e-05	0.00158	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—CARD9—ankylosing spondylitis	9.42e-05	0.00157	CbGpPWpGaD
Caffeine—ATM—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	9.4e-05	0.00157	CbGpPWpGaD
Caffeine—PIK3CB—Disease—B3GNT2—ankylosing spondylitis	9.38e-05	0.00157	CbGpPWpGaD
Caffeine—Hypersensitivity—Methotrexate—ankylosing spondylitis	9.23e-05	0.00171	CcSEcCtD
Caffeine—PIK3CD—Metabolism—B3GNT2—ankylosing spondylitis	9.01e-05	0.00151	CbGpPWpGaD
Caffeine—ABCB1—Allograft Rejection—IL1A—ankylosing spondylitis	8.94e-05	0.00149	CbGpPWpGaD
Caffeine—ABCB1—Allograft Rejection—IL10—ankylosing spondylitis	8.89e-05	0.00149	CbGpPWpGaD
Caffeine—ABCB1—Allograft Rejection—CD40LG—ankylosing spondylitis	8.89e-05	0.00149	CbGpPWpGaD
Caffeine—PIK3CD—Adaptive Immune System—CD40LG—ankylosing spondylitis	8.82e-05	0.00147	CbGpPWpGaD
Caffeine—PIK3CD—Signaling by GPCR—PTGER4—ankylosing spondylitis	8.75e-05	0.00146	CbGpPWpGaD
Caffeine—PIK3CD—Innate Immune System—HLA-B—ankylosing spondylitis	8.74e-05	0.00146	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—HLA-C—ankylosing spondylitis	8.61e-05	0.00144	CbGpPWpGaD
Caffeine—ABCB1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	8.49e-05	0.00142	CbGpPWpGaD
Caffeine—ABCB1—Allograft Rejection—HLA-B—ankylosing spondylitis	8.45e-05	0.00141	CbGpPWpGaD
Caffeine—PRKDC—Immune System—IL1A—ankylosing spondylitis	8.41e-05	0.00141	CbGpPWpGaD
Caffeine—PIK3CB—GPCR downstream signaling—PTGER4—ankylosing spondylitis	8.4e-05	0.0014	CbGpPWpGaD
Caffeine—PIK3CD—Adaptive Immune System—HLA-B—ankylosing spondylitis	8.39e-05	0.0014	CbGpPWpGaD
Caffeine—PRKDC—Immune System—CD40LG—ankylosing spondylitis	8.36e-05	0.0014	CbGpPWpGaD
Caffeine—ADORA2B—GPCR downstream signaling—PTGER4—ankylosing spondylitis	8.32e-05	0.00139	CbGpPWpGaD
Caffeine—PRKDC—Immune System—HLA-B—ankylosing spondylitis	7.95e-05	0.00133	CbGpPWpGaD
Caffeine—Rash—Methotrexate—ankylosing spondylitis	7.9e-05	0.00146	CcSEcCtD
Caffeine—Dermatitis—Methotrexate—ankylosing spondylitis	7.89e-05	0.00146	CcSEcCtD
Caffeine—PIK3CB—Metabolism—B3GNT2—ankylosing spondylitis	7.86e-05	0.00131	CbGpPWpGaD
Caffeine—ABCB1—Allograft Rejection—HLA-A—ankylosing spondylitis	7.83e-05	0.00131	CbGpPWpGaD
Caffeine—PIK3CD—Adaptive Immune System—HLA-A—ankylosing spondylitis	7.78e-05	0.0013	CbGpPWpGaD
Caffeine—PIK3CD—Innate Immune System—CRP—ankylosing spondylitis	7.73e-05	0.00129	CbGpPWpGaD
Caffeine—PIK3CB—Adaptive Immune System—CD40LG—ankylosing spondylitis	7.69e-05	0.00129	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by GPCR—PTGER4—ankylosing spondylitis	7.63e-05	0.00127	CbGpPWpGaD
Caffeine—PIK3CB—Innate Immune System—HLA-B—ankylosing spondylitis	7.62e-05	0.00127	CbGpPWpGaD
Caffeine—ADORA2B—Signaling by GPCR—PTGER4—ankylosing spondylitis	7.56e-05	0.00126	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—HLA-C—ankylosing spondylitis	7.5e-05	0.00125	CbGpPWpGaD
Caffeine—PIK3CA—Regulation of toll-like receptor signaling pathway—TNF—ankylosing spondylitis	7.5e-05	0.00125	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—IL1RN—ankylosing spondylitis	7.48e-05	0.00125	CbGpPWpGaD
Caffeine—PIK3CA—Adaptive Immune System—CD79A—ankylosing spondylitis	7.43e-05	0.00124	CbGpPWpGaD
Caffeine—PIK3CD—Innate Immune System—TLR4—ankylosing spondylitis	7.41e-05	0.00124	CbGpPWpGaD
Caffeine—PIK3CA—Disease—B3GNT2—ankylosing spondylitis	7.39e-05	0.00124	CbGpPWpGaD
Caffeine—PRKDC—Immune System—HLA-A—ankylosing spondylitis	7.37e-05	0.00123	CbGpPWpGaD
Caffeine—PIK3CB—Adaptive Immune System—HLA-B—ankylosing spondylitis	7.32e-05	0.00122	CbGpPWpGaD
Caffeine—ADORA1—GPCR downstream signaling—PTGER4—ankylosing spondylitis	7.08e-05	0.00118	CbGpPWpGaD
Caffeine—PRKDC—Immune System—CRP—ankylosing spondylitis	7.03e-05	0.00117	CbGpPWpGaD
Caffeine—PDE4B—GPCR downstream signaling—PTGER4—ankylosing spondylitis	6.99e-05	0.00117	CbGpPWpGaD
Caffeine—PIK3CB—Adaptive Immune System—HLA-A—ankylosing spondylitis	6.78e-05	0.00113	CbGpPWpGaD
Caffeine—PRKDC—Immune System—TLR4—ankylosing spondylitis	6.74e-05	0.00113	CbGpPWpGaD
Caffeine—PIK3CB—Innate Immune System—CRP—ankylosing spondylitis	6.73e-05	0.00113	CbGpPWpGaD
Caffeine—PIK3CA—GPCR downstream signaling—PTGER4—ankylosing spondylitis	6.62e-05	0.00111	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—CD79A—ankylosing spondylitis	6.56e-05	0.0011	CbGpPWpGaD
Caffeine—CYP1A1—Aryl Hydrocarbon Receptor—TNF—ankylosing spondylitis	6.53e-05	0.00109	CbGpPWpGaD
Caffeine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—ankylosing spondylitis	6.53e-05	0.00109	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—IL1RN—ankylosing spondylitis	6.52e-05	0.00109	CbGpPWpGaD
Caffeine—PIK3CB—Innate Immune System—TLR4—ankylosing spondylitis	6.46e-05	0.00108	CbGpPWpGaD
Caffeine—ADORA1—Signaling by GPCR—PTGER4—ankylosing spondylitis	6.43e-05	0.00107	CbGpPWpGaD
Caffeine—PDE4B—Signaling by GPCR—PTGER4—ankylosing spondylitis	6.35e-05	0.00106	CbGpPWpGaD
Caffeine—PIK3CD—Signaling by GPCR—MMP3—ankylosing spondylitis	6.23e-05	0.00104	CbGpPWpGaD
Caffeine—PIK3CA—Metabolism—B3GNT2—ankylosing spondylitis	6.19e-05	0.00103	CbGpPWpGaD
Caffeine—PIK3CA—Adaptive Immune System—CD40LG—ankylosing spondylitis	6.06e-05	0.00101	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by GPCR—PTGER4—ankylosing spondylitis	6.01e-05	0.001	CbGpPWpGaD
Caffeine—PIK3CA—Innate Immune System—HLA-B—ankylosing spondylitis	6e-05	0.001	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—HLA-C—ankylosing spondylitis	5.91e-05	0.000988	CbGpPWpGaD
Caffeine—PIK3CA—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	5.82e-05	0.000972	CbGpPWpGaD
Caffeine—PIK3CA—Adaptive Immune System—HLA-B—ankylosing spondylitis	5.76e-05	0.000964	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—CD79A—ankylosing spondylitis	5.72e-05	0.000957	CbGpPWpGaD
Caffeine—ADORA2A—GPCR downstream signaling—PTGER4—ankylosing spondylitis	5.46e-05	0.000913	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by GPCR—MMP3—ankylosing spondylitis	5.43e-05	0.000908	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—IL1A—ankylosing spondylitis	5.38e-05	0.0009	CbGpPWpGaD
Caffeine—ADORA2B—Signaling by GPCR—MMP3—ankylosing spondylitis	5.38e-05	0.000899	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—CD40LG—ankylosing spondylitis	5.35e-05	0.000895	CbGpPWpGaD
Caffeine—PIK3CA—Adaptive Immune System—HLA-A—ankylosing spondylitis	5.34e-05	0.000893	CbGpPWpGaD
Caffeine—PIK3CA—Innate Immune System—CRP—ankylosing spondylitis	5.31e-05	0.000887	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—PTGER4—ankylosing spondylitis	5.17e-05	0.000864	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—IL1RN—ankylosing spondylitis	5.14e-05	0.000859	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—HLA-B—ankylosing spondylitis	5.09e-05	0.000851	CbGpPWpGaD
Caffeine—PIK3CA—Innate Immune System—TLR4—ankylosing spondylitis	5.09e-05	0.00085	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—PTGER4—ankylosing spondylitis	4.96e-05	0.000829	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—HLA-A—ankylosing spondylitis	4.72e-05	0.000788	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—IL1A—ankylosing spondylitis	4.69e-05	0.000784	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—CD40LG—ankylosing spondylitis	4.66e-05	0.00078	CbGpPWpGaD
Caffeine—ADORA1—Signaling by GPCR—MMP3—ankylosing spondylitis	4.57e-05	0.000765	CbGpPWpGaD
Caffeine—PDE4B—Signaling by GPCR—MMP3—ankylosing spondylitis	4.52e-05	0.000756	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—CD79A—ankylosing spondylitis	4.51e-05	0.000754	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—PTGER4—ankylosing spondylitis	4.51e-05	0.000753	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—CRP—ankylosing spondylitis	4.5e-05	0.000752	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—PTGER4—ankylosing spondylitis	4.46e-05	0.000746	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—HLA-B—ankylosing spondylitis	4.44e-05	0.000742	CbGpPWpGaD
Caffeine—PIK3CD—Disease—HLA-A—ankylosing spondylitis	4.35e-05	0.000728	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—TLR4—ankylosing spondylitis	4.31e-05	0.000721	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by GPCR—MMP3—ankylosing spondylitis	4.28e-05	0.000715	CbGpPWpGaD
Caffeine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—ankylosing spondylitis	4.16e-05	0.000696	CbGpPWpGaD
Caffeine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—ankylosing spondylitis	4.16e-05	0.000696	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—HLA-A—ankylosing spondylitis	4.11e-05	0.000687	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—CRP—ankylosing spondylitis	3.92e-05	0.000656	CbGpPWpGaD
Caffeine—PIK3CB—Disease—HLA-A—ankylosing spondylitis	3.8e-05	0.000634	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—PTGER4—ankylosing spondylitis	3.8e-05	0.000634	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—TLR4—ankylosing spondylitis	3.76e-05	0.000629	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—PTGER4—ankylosing spondylitis	3.75e-05	0.000627	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—IL1A—ankylosing spondylitis	3.7e-05	0.000618	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—MMP3—ankylosing spondylitis	3.68e-05	0.000615	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—CD40LG—ankylosing spondylitis	3.68e-05	0.000614	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—B3GNT2—ankylosing spondylitis	3.61e-05	0.000604	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—PTGER4—ankylosing spondylitis	3.55e-05	0.000593	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—MMP3—ankylosing spondylitis	3.53e-05	0.00059	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—HLA-B—ankylosing spondylitis	3.5e-05	0.000584	CbGpPWpGaD
Caffeine—ABCB1—Allograft Rejection—TNF—ankylosing spondylitis	3.38e-05	0.000565	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—B3GNT2—ankylosing spondylitis	3.26e-05	0.000544	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—HLA-A—ankylosing spondylitis	3.24e-05	0.000542	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—MMP3—ankylosing spondylitis	3.21e-05	0.000536	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—MMP3—ankylosing spondylitis	3.18e-05	0.000531	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—CRP—ankylosing spondylitis	3.09e-05	0.000517	CbGpPWpGaD
Caffeine—PIK3CA—Disease—HLA-A—ankylosing spondylitis	2.99e-05	0.0005	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—TLR4—ankylosing spondylitis	2.96e-05	0.000495	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—PTGER4—ankylosing spondylitis	2.93e-05	0.00049	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—MMP3—ankylosing spondylitis	2.7e-05	0.000452	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—MMP3—ankylosing spondylitis	2.67e-05	0.000446	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—MMP3—ankylosing spondylitis	2.53e-05	0.000423	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—B3GNT2—ankylosing spondylitis	2.36e-05	0.000394	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—B3GNT2—ankylosing spondylitis	2.35e-05	0.000394	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—B3GNT2—ankylosing spondylitis	2.22e-05	0.000372	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—MMP3—ankylosing spondylitis	2.09e-05	0.000349	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—B3GNT2—ankylosing spondylitis	2.04e-05	0.000341	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—B3GNT2—ankylosing spondylitis	1.78e-05	0.000297	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—B3GNT2—ankylosing spondylitis	1.67e-05	0.00028	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	1.67e-05	0.000279	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—B3GNT2—ankylosing spondylitis	1.66e-05	0.000277	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—B3GNT2—ankylosing spondylitis	1.42e-05	0.000237	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—B3GNT2—ankylosing spondylitis	1.09e-05	0.000183	CbGpPWpGaD
